News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cispharma Inc.: Unapproved Drugs, Faulty Tablets, Bloody Accident Lead to Warning Letter for Generics Company


7/18/2013 7:49:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Generic drug products have gained huge market share since the 1984 passage of the Hatch-Waxman Act, which for the first time established a pathway for the approval of generic drugs (excluding the 'Paper NDA' pathway). By many estimates, generic competitors control more than 80% of the market once they are introduced, creating a strong incentive for many companies to compete for the market share of popular drugs. But as a recent Warning Letter from the US Food and Drug Administration (FDA) points out, sometimes even the most common of generic drugs are manufactured outside of acceptable standards.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at FDA


comments powered by Disqus
News Release
FDA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES